1. Home
  2. MAIA vs FEIM Comparison

MAIA vs FEIM Comparison

Compare MAIA & FEIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MAIA
  • FEIM
  • Stock Information
  • Founded
  • MAIA 2018
  • FEIM 1961
  • Country
  • MAIA United States
  • FEIM United States
  • Employees
  • MAIA N/A
  • FEIM N/A
  • Industry
  • MAIA Biotechnology: Pharmaceutical Preparations
  • FEIM Electrical Products
  • Sector
  • MAIA Health Care
  • FEIM Industrials
  • Exchange
  • MAIA Nasdaq
  • FEIM Nasdaq
  • Market Cap
  • MAIA 62.4M
  • FEIM 119.5M
  • IPO Year
  • MAIA 2022
  • FEIM N/A
  • Fundamental
  • Price
  • MAIA $2.82
  • FEIM $12.80
  • Analyst Decision
  • MAIA
  • FEIM
  • Analyst Count
  • MAIA 0
  • FEIM 0
  • Target Price
  • MAIA N/A
  • FEIM N/A
  • AVG Volume (30 Days)
  • MAIA 60.0K
  • FEIM 19.0K
  • Earning Date
  • MAIA 11-05-2024
  • FEIM 12-10-2024
  • Dividend Yield
  • MAIA N/A
  • FEIM 7.98%
  • EPS Growth
  • MAIA N/A
  • FEIM N/A
  • EPS
  • MAIA N/A
  • FEIM 0.62
  • Revenue
  • MAIA N/A
  • FEIM $57,943,000.00
  • Revenue This Year
  • MAIA N/A
  • FEIM N/A
  • Revenue Next Year
  • MAIA N/A
  • FEIM N/A
  • P/E Ratio
  • MAIA N/A
  • FEIM $20.24
  • Revenue Growth
  • MAIA N/A
  • FEIM 28.82
  • 52 Week Low
  • MAIA $0.82
  • FEIM $7.20
  • 52 Week High
  • MAIA $5.99
  • FEIM $14.50
  • Technical
  • Relative Strength Index (RSI)
  • MAIA 50.98
  • FEIM 52.77
  • Support Level
  • MAIA $2.36
  • FEIM $12.17
  • Resistance Level
  • MAIA $2.72
  • FEIM $12.72
  • Average True Range (ATR)
  • MAIA 0.22
  • FEIM 0.37
  • MACD
  • MAIA 0.02
  • FEIM 0.01
  • Stochastic Oscillator
  • MAIA 72.28
  • FEIM 45.37

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company. The company develops targeted immunotherapies for cancer. The company is an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's program is THIO, a potential cancer telomere-targeting agent in clinical development for the treatment of telomerase-positive cancer cells.

About FEIM Frequency Electronics Inc.

Frequency Electronics Inc is engaged in the design, development, and manufacture of high-precision timing, and frequency control products for space, air, sea, and terrestrial applications. The company has FEI-NY and FEI-Zyfer reportable segments. It derives the majority of its revenues from the FEI-NY segment. FEI-NY segment operations consist principally of precision time and frequency control products used in three principal markets namely communication satellites (both commercial and U.S. Government-funded); terrestrial cellular telephone or other ground-based telecommunication stations; and other components and systems for the U.S. military.

Share on Social Networks: